Stay updated with breaking news from Nodify Lung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor conferences: William Blair 44th Annual Growth Stock Conference...
Data highlights ability of the Nodify XL2 test to identify benign nodules in patients with emphysema ...
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1...
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, today announced the pricing of its underwritten offering of 17,391,832 shares of its common stock at a price to...
Persistent, high double-digit growth in Lung Diagnostic test volume - growing 65% in FY2023 versus FY2022 - and the sixth consecutive quarter with greater than 50% year-over-year growth; Ongoing...